Press Releases September 15, 2026 02:15 AM

NOTICE TO DISREGARD

HUHUTECH International Group Inc. Issues Notice to Disregard Previous News Release

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
HUHUT

HUHUTECH International Group Inc. has issued a formal notice asking journalists and readers to disregard a previous news release from November 7, 2025, which claimed that its U.S. subsidiary secured a $3 million order following its Nasdaq IPO. This retraction may raise concerns about the accuracy of prior statements from the company.

NOTICE TO DISREGARD
HUHUT
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • HUHUTECH International Group Inc. has withdrawn a previous announcement regarding a $3 million order by its U.S. subsidiary.
  • The retracted statement related to a milestone following the company’s Nasdaq IPO, potentially impacting investor confidence.
  • The company is proactively communicating corrections through official channels and investor relations contacts.

WUXI, China, Sept. 15, 2026 (GLOBE NEWSWIRE) -- We are advised by HUHUTECH International Group Inc. that journalists and other readers should disregard the news release “HUHUTECH’s U.S. Subsidiary Secures First Order Worth $3.0 Million, Marking a Breakthrough Following Its Nasdaq IPO” issued November 7, 2025 over GlobeNewswire.

Company Contact

Email: [email protected]
Website: www.huhutech.com

Investor Relations Contact

Matthew Abenante, IRC
President
Strategic Investor Relations LLC
Phone: +1 (347) 947-2093
Email: [email protected]
Web: www.strategic-ir.com


Risks

  • Potential damage to the company's credibility and investor trust due to the retraction of key information.
  • Uncertainty about the company's actual business performance and order book, affecting valuations.
  • Impact on the technology and Nasdaq-listed small cap sectors due to newsworthiness and potential volatility in stock price.

More from Press Releases

UroGen Reports $68.0 Million of ZUSDURI Revenue and Provides Third Quarter 2026 Financial Results and Highlights Nov 4, 2026 BioVie Announces Pricing of $4.74 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules Nov 4, 2026 Jasper Therapeutics Announces 1-for-30 Reverse Stock Split Nov 4, 2026 Twin Disc Announces First Quarter Results Nov 4, 2026 UniFirst Declares Increased Cash Dividends Oct 30, 2026